BCRX icon

BioCryst Pharmaceuticals

238 hedge funds and large institutions have $915M invested in BioCryst Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 84 increasing their positions, 71 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding:

more funds holding in top 10

Funds holding in top 10:

0.58% less ownership

Funds ownership: 87.89%87.32% (-0.58%)

15% less capital invested

Capital invested by funds: $1.08B → $915M (-$163M)

16% less call options, than puts

Call options by funds: $7.81M | Put options by funds: $9.31M

Holders
238
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
5
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$7.81M
Puts
$9.31M
Net Calls
Net Calls Change

Top Sellers

1 -$21.7M
2 -$11.9M
3 -$11.8M
4
Norges Bank
Norges Bank
Norway
-$6.15M
5
Fidelity Investments
Fidelity Investments
Massachusetts
-$4.47M
Name Holding Trade Value Shares
Change
Change in
Stake
76
$813K
77
$793K
78
$772K
79
$739K
80
$738K
81
$718K
82
$695K
83
$665K
84
$622K
85
$621K
86
$611K
87
$594K
88
$579K
89
$578K
90
$505K
91
$505K
92
$496K
93
$479K
94
$475K
95
$469K
96
$455K
97
$452K
98
$449K
99
$411K
100
$407K